Bronchscope trackers and softwareprototypes

The National Institutes of Health (NIH), Clinical Center (CC),Center for Interventional Oncology intends to enter into a contract on a sole source basis, under the authority of 41 U.S.C. 253 (c) (1) and FAR 6.302-1(a) (2) (ii) and HHSAR 306.302-1 (a) (2) (ii), a contract to develop and validate navigation tools integrated with Interventional Oncology software for improved visualization and probe placement during image-guided radiofrequency ablation(RFA) of liver tumors.

If there are other sources able to supply the required material, they must respond by submitting a capability statement within 10 days of publication of this synopsis.

This notice of intent is not a request for competitive proposals. However, all proposals received prior to the closing date of this synopsis will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Deliveries should be Hand Carried or sent via other mail or package Delivery Services. NO COLLECT CALLS OR FACSIMILE TRANSMISSIONS WILL BE ACCEPTED. RESPONDENTS MAY SUBMIT THEIR CAPABILITY STATEMENTS VIA E-MAIL TO THE POINT OF CONTACT LISTED IN THIS NOTICE OF INTENT SYNOPSIS.

The Clinical Center (CC) Interventional Oncology plans to procure, on a sole source basis, from 3T Technologies Dr. Zion Tsz Ho Tse, 4161 Blackland Dr. Marietta, GA 30067, procure a hardware and software protptype used to segment, plan and execute treatment of liver tumors. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(2) and 13.501-(a)(1) to use simplified procedures for commercial acquisitions. The North American Industry Classification System Code is 514990 and the business size standard of $15.0. Only one award will be made as a result of this solicitation. This will be a firm fixed price type contract.

To the maximum extent possible, please submit non-proprietary information. Any proprietary information submitted should be identified as such and will be properly protected from disclosure.
Interested Offerors should submit their capability statement not exceeding ten (10) pages in length, excluding standard brochures. SUBMISSIONS ARE DUE no later than 9:00 a.m., Eastern Time, September 6,2019. The capabilities response shall be e-mailed to: gakinbinu@nih.gov .

All information received in response to this notice that is marked Proprietary will be handled accordingly. Information provided in response to this notice will be used to assess alternatives available for determining how to proceed in the acquisition process. This notice is part of Government Market Research, a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for or award a competitive contract.

The NIH/CC will use the information submitted in response to this notice at its discretion and will not provide comments to any submission; however, the content of any responses to this notice may be reflected in subsequent solicitation. NIH/CC/OPC reserves the right to contact any respondent to this notice for the sole purpose of enhancing NIH/CC/OPC 's understanding of the notice submission.

Responses to this Notice of Intent shall be submitted before the closing date and time to the attention of the Contract Specialist listed below.

Gail Akinbinu
Contract Specialist
Offic eof Purchasing and Contracts
6707 Democracy Boulevard Suite 106
Bethesda, MD 20892

.